Cargando…
How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
We suggested de-escalation would be possible for cervical cancer like human papillomavirus (HPV)-related oropharyngeal cancer. However, the classification was based on tumor shrinkage that can be obtained after half of the treatment was finished. Our other article found adverse factors which can be...
Autores principales: | Murakami, Naoya, Kuno, Ikumi, Yoshida, Hiroshi, Shiraishi, Kouya, Kato, Tomoyasu, Igaki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944302/ https://www.ncbi.nlm.nih.gov/pubmed/35039847 http://dx.doi.org/10.1093/jrr/rrab130 |
Ejemplares similares
-
Endometrial cancer arising after complete remission of uterine malignant lymphoma: A case report and mutation analysis
por: Kuno, Ikumi, et al.
Publicado: (2019) -
Molecular Pathology of Human Papilloma Virus-Negative Cervical Cancers
por: Yoshida, Hiroshi, et al.
Publicado: (2021) -
Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix
por: Takayanagi, Daisuke, et al.
Publicado: (2021) -
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
por: Kuno, Ikumi, et al.
Publicado: (2021) -
Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer
por: Asami, Yuka, et al.
Publicado: (2022)